In addition, plasma phosphorylated tau (p-tau) and amyloid-beta may be more specific to the brain pathology in dementia as compared to plasma NfL, GFAP, and t-tau [6], but these biomarkers were not available in the present study. This evidence concerns the gene MAPT and dementia.